Acute unilateral myopia induced by add-on aripiprazole: A case report

Basit Öğe Kaydı
dc.contributor.authorBulut, Mahmut
dc.contributor.authorAtli, Abdullah
dc.contributor.authorKaya, Mehmet Cemal
dc.contributor.authorDemir, Süleyman
dc.contributor.authorİbiloğlu, Aslıhan Okan
dc.contributor.authorGüneş, Mehmet
dc.contributor.authorYüksel, Harun
dc.date.accessioned2024-04-24T19:07:59Z
dc.date.available2024-04-24T19:07:59Z
dc.date.issued2016
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe partial agonist aripiprazole is a novel atypical antipsychotic with a relatively safer side effect profile. Acute unilateral myopia is a very rare condition that is commonly associated with drug use. Here, we present a woman diagnosed with obsessive-compulsive disorder (OCD) and major depressive disorder (MDD) who have been treated for two years in our clinic. She was on fluoxetine (Prozac) 80 mg/day when adding aripiprazole (Abilify) 10 mg/day as an augmentation agent has triggered unilateral myopia. After cessation of aripirazole her myopia has disappeared. Psychiatrists should keep in mind that unilateral myopia as a side effect may develop after combining aripiprazole with fluoxetine in patients with OCD and MDD.en_US
dc.identifier.endpage71en_US
dc.identifier.issn1017-7833
dc.identifier.issn1302-9657
dc.identifier.issue1en_US
dc.identifier.startpage68en_US
dc.identifier.trdizinid208472
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/208472
dc.identifier.urihttps://hdl.handle.net/11468/27707
dc.identifier.volume26en_US
dc.indekslendigikaynakTR-Dizin
dc.language.isoenen_US
dc.relation.ispartofKlinik Psikofarmakoloji Bülteni
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleAcute unilateral myopia induced by add-on aripiprazole: A case reporten_US
dc.titleAcute unilateral myopia induced by add-on aripiprazole: A case report
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu